[go: up one dir, main page]

DK1450770T3 - Farmaceutisk præparat, der omfatter en 5HT1-receptoragonist - Google Patents

Farmaceutisk præparat, der omfatter en 5HT1-receptoragonist

Info

Publication number
DK1450770T3
DK1450770T3 DK02792887T DK02792887T DK1450770T3 DK 1450770 T3 DK1450770 T3 DK 1450770T3 DK 02792887 T DK02792887 T DK 02792887T DK 02792887 T DK02792887 T DK 02792887T DK 1450770 T3 DK1450770 T3 DK 1450770T3
Authority
DK
Denmark
Prior art keywords
pharmaceutical composition
receptor agonist
agonist
receptor
pharmaceutical
Prior art date
Application number
DK02792887T
Other languages
English (en)
Inventor
Robert William Baker
Alan David Dow
Simon John Summers
Julian Westrup
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB0129117.8A external-priority patent/GB0129117D0/en
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Application granted granted Critical
Publication of DK1450770T3 publication Critical patent/DK1450770T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404Indoles, e.g. pindolol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404Indoles, e.g. pindolol
    • A61K31/4045Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/41641,3-Diazoles
    • A61K31/4172Imidazole-alkanecarboxylic acids, e.g. histidine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0002Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007Effervescent
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2009Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
DK02792887T 2001-12-05 2002-12-04 Farmaceutisk præparat, der omfatter en 5HT1-receptoragonist DK1450770T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB0129117.8A GB0129117D0 (en) 2001-12-05 2001-12-05 Pharmaceutical composition
EP02792887A EP1450770B1 (en) 2001-12-05 2002-12-04 Pharmaceutical composition comprising a 5ht1 receptor agonist
EP0231715 2002-12-04

Publications (1)

Publication Number Publication Date
DK1450770T3 true DK1450770T3 (da) 2005-08-01

Family

ID=34424757

Family Applications (1)

Application Number Title Priority Date Filing Date
DK02792887T DK1450770T3 (da) 2001-12-05 2002-12-04 Farmaceutisk præparat, der omfatter en 5HT1-receptoragonist

Country Status (2)

Country Link
DK (1) DK1450770T3 (da)
SI (1) SI1450770T1 (da)

Also Published As

Publication number Publication date
SI1450770T1 (da) 2005-08-31

Similar Documents

Publication Publication Date Title
NO20032678D0 (no) NMDA reseptor agonist farmasöytiske sammensetninger
DK1446379T3 (da) Arylanilin-beta2-adrenergiske receptoragonister
PT1450770E (pt) Composicao farmaceutica compreendendo um agonista do receptor 5ht1
PL367180A1 (pl) Trwała kompozycja farmaceutyczna
FI20011478A0 (fi) Farmaseuttinen koostumus
DK1615646T4 (da) Farmaceutiske formuleringer, der indeholder methylnaltrexon
NO20033143L (no) Farmasoytisk preparat
ATE450505T1 (de) Cb 1 rezeptor inversagonisten
NO20042737L (no) Peroksisomproliferatoraktiverte receptoragonister
DE60217390D1 (de) Bicalutamid enthaltende pharmazeutische zusammensetzung
ATE381541T1 (de) Aminotetralinderivate, antagonisten von muscarinrezeptoren
DE60324018D1 (de) Agonisten
DE10291905D2 (de) Pharmazeutische Zusammensetzung
NO20013978L (no) Dopamin D1 reseptor agonist forbindelser
DK1450770T3 (da) Farmaceutisk præparat, der omfatter en 5HT1-receptoragonist
IS7581A (is) Lyfjasamsetning
EE200300465A (et) Püridoindolooni derivaatidel põhinevad farmatseutilised kompositsioonid
EE200300378A (et) Farmatseutiline kompositsioon
FI20012242A0 (fi) Uudet farmaseuttiset yhdisteet
NO20041776L (no) En ny G-proteinkoblet reseptor, GAVE10
DK1347760T3 (da) Farmaceutiske kompositioner med NMDA receptor agonister
ITRM20030201A1 (it) Dispositivo di appoggio a cerniera sferica per ponti,
NO20040252L (no) En ny G-proteinkoblet reseptor, GAVE8
FI5468U1 (fi) Farmaseuttinen koostumus
DOP2002000508A (es) Composición farmaceutica